LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.1
41.84 84.90 1746 4003 0.4362 0.7227
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
41.84 84.90 1777 4003 0.4439 0.7282
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
41.84 84.90 147 4003 0.0367 0.1038
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
41.84 84.90 1629 4003 0.4069 0.7013
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 1487 4287 0.3468 0.6586
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 1508 4287 0.3517 0.6627
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 1804 4287 0.4207 0.7162
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 1832 4287 0.4273 0.7209
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 169 4287 0.0394 0.1294
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
43.55 84.90 1769 4287 0.4126 0.7103
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 1505 4539 0.3315 0.6501
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 1525 4539 0.3359 0.6539
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 1929 4539 0.4249 0.7230
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 1950 4539 0.4295 0.7262
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 187 4539 0.0412 0.1475
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
45.25 84.90 1856 4539 0.4088 0.7114
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 1526 4952 0.3081 0.6364
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 1547 4952 0.3124 0.6402
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 1923 4952 0.3883 0.7021
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 1944 4952 0.3925 0.7053
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 227 4952 0.0458 0.1825
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
46.95 84.90 1956 4952 0.3950 0.7071
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
48.65 84.90 1767 5328 0.3316 0.6625
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
48.65 84.90 1788 5328 0.3355 0.6658
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
48.65 84.90 2034 5328 0.3817 0.7021
MN20160318_Q02
J05